These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28504893)

  • 21. Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Xiao G; Li Y; Qiang X; Xu R; Zheng Y; Cao Z; Luo L; Yang X; Sang Z; Su F; Deng Y
    Bioorg Med Chem; 2017 Feb; 25(3):1030-1041. PubMed ID: 28011206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
    Wang T; Liu XH; Guan J; Ge S; Wu MB; Lin JP; Yang LR
    Eur J Med Chem; 2019 May; 169():200-223. PubMed ID: 30884327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.
    Ramsay RR; Tipton KF
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28714881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Wang H; Yu L; Wang H; Ma Q; Ye M; Han X; Liu W
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5053-5059. PubMed ID: 29033232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.
    Passos CS; Simões-Pires CA; Nurisso A; Soldi TC; Kato L; de Oliveira CM; de Faria EO; Marcourt L; Gottfried C; Carrupt PA; Henriques AT
    Phytochemistry; 2013 Feb; 86():8-20. PubMed ID: 23261030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B.
    Mazej T; Knez D; Meden A; Gobec S; Sova M
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
    He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
    Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.
    Zou D; Liu R; Lv Y; Guo J; Zhang C; Xie Y
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270781. PubMed ID: 37955252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
    Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents.
    Xu Y; Zhang J; Wang H; Mao F; Bao K; Liu W; Zhu J; Li X; Zhang H; Li J
    ACS Chem Neurosci; 2019 Jan; 10(1):482-496. PubMed ID: 30110536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of 2-acetylphenol-donepezil hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Zhu G; Wang K; Shi J; Zhang P; Yang D; Fan X; Zhang Z; Liu W; Sang Z
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126625. PubMed ID: 31444085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
    Yang HL; Cai P; Liu QH; Yang XL; Li F; Wang J; Wu JJ; Wang XB; Kong LY
    Eur J Med Chem; 2017 Sep; 138():715-728. PubMed ID: 28728104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
    Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
    J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Bautista-Aguilera ÓM; Alonso JM; Catto M; Iriepa I; Knez D; Gobec S; Marco-Contelles J
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
    Zheng H; Youdim MB; Fridkin M
    ACS Chem Biol; 2010 Jun; 5(6):603-10. PubMed ID: 20455574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer's disease agents.
    Yang J; Yun Y; Miao Y; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):805-814. PubMed ID: 32183602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Benek O; Soukup O; Pasdiorova M; Hroch L; Sepsova V; Jost P; Hrabinova M; Jun D; Kuca K; Zala D; Ramsay RR; Marco-Contelles J; Musilek K
    ChemMedChem; 2016 Jun; 11(12):1264-9. PubMed ID: 26427608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease.
    Hafez DE; Dubiel M; La Spada G; Catto M; Reiner-Link D; Syu YT; Abdel-Halim M; Hwang TL; Stark H; Abadi AH
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2175821. PubMed ID: 36789662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
    Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
    Yang HL; Cai P; Liu QH; Yang XL; Fang SQ; Tang YW; Wang C; Wang XB; Kong LY
    Bioorg Med Chem; 2017 Nov; 25(21):5917-5928. PubMed ID: 28988627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.